# Use of Biperiden for the Prevention of Post-traumatic Epilepsy

> **NCT01048138** · PHASE3 · TERMINATED · sponsor: **Federal University of São Paulo** · enrollment: 123 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Biperiden Lactate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01048138
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-01-31
- **Primary completion:** 2022-12-02
- **Final completion:** 2022-12-02
- **Target enrollment:** 123 (ACTUAL)
- **Why stopped:** Recruitment and funding issues, together with the event of the SARS-CoV-2 pandemic prompted an adjustment in the study design to stop enrollment at 123 patients.
- **Last updated:** 2023-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01048138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01048138, "Use of Biperiden for the Prevention of Post-traumatic Epilepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01048138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*